Summary
This report presents the Capital Market Outlook for May 2026, detailing macroeconomic strategies and market views influenced by recent global events. It outlines the impact of the Hormuz oil crisis on oil supply and demand, noting that the effective supply imbalance is closer to 10 million barrels per day rather than the 20 million barrels per day initially reported. The report highlights how the crisis has affected Europe and Asia, particularly due to their dependence on Middle Eastern oil imports. Additionally, it discusses China's emergence as a significant player in the pharmaceutical sector, detailing its rapid advancements in drug development and the factors supporting this growth. The report also covers global deal activity in 2026, noting a strong start to mergers and acquisitions, driven by fiscal tailwinds and a robust macroeconomic backdrop. The analysis includes portfolio considerations, emphasizing the resilience of U.S. equities and the importance of maintaining a quality-focused investment strategy amid ongoing geopolitical uncertainties.
